More about research
Inreda Diabetic BV developed the first artificial bihormonal pancreas (AP) to improve treatment of diabetes by automatically controlling glucose concentrations.
Classical Galactosemia (CG) is an inborn error of galactose metabolism. In spite of early diagnosis and dietary treatment many patients develop neurological and cognitive complications.
Current care in Dutch chronic pancreatitis proved not to be in accordance with the European Guidelines which may indicate suboptimal care.
Fatigue is a highly prevalent problem in inflammatory disease patients. Not only in active disease, but also in patients in remission.
The Dutch neonatal screening program allows for the detection of congenital central hypothyroidism (CCeH) and facilitated identification of patients with CCeH over the past decades.
Researchers at the Laboratory Genetic Metabolic Disease are looking at drug development in a different way. Their computational pipelines are greatly accelerating the drug discovery process.
Various neurodegenerative disorders have been associated with an inappropriate reaction to dietary gluten intake. The underlying neuropathological mechanism is still unclear.
One of our main goals in clinical research in patients with polyposis syndromes is the optimization and personalization of endoscopic surveillance.
In this project we aim to understand the role of bile acids (and its dynamics) in energy, fat and glucose homeostasis, and in inflammation.